α-Benzyl-N-methylphenethylamine (BNMPA), an impurity of illicit methamphetamine synthesis: III. Detection of BNMPA and metabolites in urine of methamphetamine users

Journal of Analytical Toxicology

Volumn 20, Issue 2, 1996, Pages 89-92

  Moore, Karla A ^a   Ismaiel, Abd ^a   Poklis, Alphonse ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIPHENYL 2 PROPANOL; 1,3 DIPHENYLISOPROPYLAMINE; ALPHA BENZYL N METHYLTYRAMINE; ALPHA BENZYLTYRAMINE; DIBENZYL KETONE; DRUG METABOLITE; ILLICIT DRUG; METHAMPHETAMINE; N METHYL 1,3 DIPHENYLISOPROPYLAMINE; UNCLASSIFIED DRUG;

ARTICLE; DRUG DETERMINATION; DRUG IMPURITY; DRUG SCREENING; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; URINE LEVEL;

EID: 0029918815     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/20.2.89     Document Type: Article

References (19)

1. O. Ray. Drugs Society and Human Behavior. C.V. Mosby Co., St. Louis, MO, 1978, pp 277-88.
2. J.P. Morgan and D.V. Kagan. Street amphetamine quality and the Controlled Substances Act of 1970. J. Psychedelic Drugs 10: 303-17 (1978).
3. B. Heischober and R.W. Derlet. Update on amphetamine abuse. West J. Med. 151: 70-71 (1989).
4. R.S. Frank. The clandestine drug laboratory situation in the United States. J. Forensic Sci. 28:18-31 (1983).
5. W.H. Soine. Clandestine drug synthesis. Med. Res. Rev. 6: 41-74 (1986).
6. A.M. van der Ark, A.M.A. Verweij, and A. Sinnema. Weakly basic impurities in illicit amphetamine. J. Forensic Sci. 23: 693-700 (1978).
7. A. Sinnema and A.M.A. Verweij. Impurities in illicit amphetamine: a review. Bull. Narcotics 33: 37-54 (1981).
8. A.M.A. Verweij. Impurities in illicit drug preparations: amphetamine and methamphetamine. Forensic Sci. Rev. 1: 2-11 (1989).
9. W.H. Soine. Contamination of clandestinely prepared drugs with synthetic by-products. In Proceedings of the 51st Annual Meeting. The Committee on Problems of Drug Dependence, Inc. L. Harris, Ed., National Institute on Drug Abuse, Rockville, MD, 1989, pp 44-50.
10. F.T. Noggle, C.R. Clark, T.W. Davenport, and S.T. Coker. Synthesis, identification, and acute toxicity of α-benzyl-N-methylphenethylamine. Contaminants in clandestine preparation of amphetamine and methamphetamine. J. Assoc. Off. Anal. Chem. 68: 1213-22 (1985).
11. K.A. Moore, A.H. Lichtman, A. Poklis, and J. Borzelleca. α-Benzyl-N-methylphenethylamine (BNMPA), an impurity of illicit methamphetamine synthesis: pharmacological evaluation and interaction with methamphetamine. Drug Alcohol Depend. 39: 83-89 (1995).
12. R.P. Barron, A.V. Kruegel, J.M. Moore, and T.C. Kram. Identification of impurities in illicit methamphetamine samples. J. Assoc. Off. Anal. Chem. 57: 1147-58 (1974).
13. K.A. Moore, W.H. Soine, and A. Poklis. α-Benzyl-N-methylphenethylamine (BNMPA), an impurity of illicit methamphetamine synthesis: I. Physical characterization and GC-MS analysis of BNMPA and anticipated metabolites in urine. J. Anal. Toxicol. 19: 542-48 (1995).
14. K.A. Moore and A. Poklis. α-Benzyl-N-Methylphenethylamine (BNMPA), an impurity of illicit methamphetamine synthesis: II. Metabolism and urinary excretion (human). J. Anal. Toxicol. 19: 549-53 (1995).
15. E.M. Thurman, M.J. Pedersen, R.L. Stout, and T. Martin Distinguishing sympathomimetic amines from amphetamine and methamphetamine in urine by gas chromatography/mass spectrometry. J. Anal. Toxicol. 16: 19-27 (1992).
16. Anonymous. Ephedra used in Colorado methamphetamine. Microgram 27: 174 (1994).
17. Anonymous. Untitled. Diversion Q. 1: 4 (1994).
18. Department of Justice, Drug Enforcement Administration. Elimination of threshold for ephedrine. Fed. Regist. 59(52): 12562-63. (1994).
19. Anonymous. Iodine watch. Microgram 26: 272 (1993).